EdgarLookup

Annovis Bio, Inc.

ANVS NYSE CIK: 0001477845 Pharmaceutical Preparations Inc. in DE
View on SEC.gov →
Overview All Filings Annual Quarterly Insiders

Recent Filings

All 285 filings →
Form Description Date
8-K FORM 8-K Mar 25, 2026
8-K FORM 8-K Mar 16, 2026
10-K 10-K Mar 13, 2026
8-K FORM 8-K Feb 12, 2026
8-K FORM 8-K Jan 28, 2026
4 OWNERSHIP DOCUMENT Dec 8, 2025
4/A OWNERSHIP DOCUMENT Nov 25, 2025
4 OWNERSHIP DOCUMENT Nov 25, 2025
4 OWNERSHIP DOCUMENT Nov 21, 2025
4 OWNERSHIP DOCUMENT Nov 18, 2025

Insider Transactions

View all →
Insider Title Type Shares Owns After Date
Hoffman Michael B Purchase 30,000 @ $4.34 2,559,739 Dec 8, 2025
Hoffman Michael B Purchase 9,200 @ $3.85 2,501,228 Nov 24, 2025
Hoffman Michael B Purchase 1,489 @ $4.13 2,482,028 Nov 24, 2025
Hoffman Michael B Purchase 10,000 @ $3.50 2,490,539 Nov 21, 2025
Hoffman Michael B Purchase 15,000 @ $2.11 2,470,539 Nov 14, 2025
Maccecchini Maria-Luisa President & CEO Purchase 97,561 @ $2.05 1,212,020 Oct 28, 2025
Hoffman Michael B Purchase 975,610 @ $2.05 2,455,539 Oct 28, 2025
Hoffman Michael B Award / Grant 5,000 @ $2.28 1,469,929 Aug 29, 2025
Hoffman Michael B Award / Grant 1,100 @ $2.57 1,464,929 Aug 19, 2025
Walsh Andrew Vice President, Finance Award / Grant 500 @ $2.90 500 Jun 16, 2025